FrancophonIA/ELRC3.0 huggingface dataset:
English: RHINISENG reduces the incidence and severity of the disease called progressive and non-progressive atrophic rhinitis in pigs.
Maltese: RHINISENG inaqqas l-inċidenza u s-severità tal-marda msejħa rinite atrofika progressiva u mhux progressiva fil-majjali.
English: Why has RHINISENG been approved?
Maltese: Għaliex ġie approvat RHINISENG?
English: What is RHINISENG?
Maltese: X'inhu RHINISENG?
English: Inactivated vaccine to prevent progressive and non-progressive atrophic rhinitis in pigs
Maltese: Vaċċin inattivat għall-prevenzjoni ta' rinite atrofika progressiva u mhux progressiva fil-majjali
English: As a consequence of reduced atrophic rhinitis disease, the incidence of respiratory symptoms and subsequent treatment with antibiotics of the pigs is also reduced.
Maltese: Bħala konsegwenza tat-tnaqqis tal-marda rinite atrofika, l-inċidenza ta' sintomi respiratorji u l-kura sussegwenti tal-majjali b'antibijotiċi titnaqqas ukoll.
English: How has RHINISENG been studied?
Maltese: Kif ġie studjat RHINISENG?
English: • for the target animal: there are mild and transitory local reactions at the injection site, resolving within few days and a transiently elevated body temperature within acceptable limits.
Maltese: • għall-annimal fil-mira: hemm reazzjonijiet ħfief u tranżitorji lokali fis-sit tal-injezzjoni, li jgħaddu wara ftit jiem u temperatura tal-ġisem kemmxejn elevata fi ħdan il-limiti aċċettabbli.
English: The safety of RHINISENG was demonstrated in several well conducted and reported laboratory and field studies.
Maltese: Is-sigurtà ta' RHINISENG intweriet f'diversi studji tal-laboratorju u fil-qasam immexxijin u rrapportati tajjeb.
English: • for the user: accidental self-injection is the only identified risk and an appropriate warning has been included in the SPC to reflect the (small) risk.
Maltese: • għall-utent: injezzjoni aċċidentali fuq l-utent hija l-unika riskju identifikat u ġiet inkluża twissija xierqa fl-SPC sabiex tirrifletti r-riskju (żgħir).
English: The efficacy of RHINISENG was demonstrated for the category of the target species for which the vaccine is recommended (gilts and sows) by the recommended route of administration (intramuscular) using the proposed schedule of administration (first vaccination at 6-8 weeks before farrowing and revaccination 3-4 weeks later).
Maltese: L-effikaċja ta' RHINISENG intweriet għall-kategorija tal-ispeċi fil-mira li għalihom ġie rrakkomandat ilvaċċin (qżieqeż nisa u majjali nisa) permezz tal-mod ta' għoti rrakkomandat (ġol-muskoli) bl-użu taliskeda ta' għoti proposta (l-ewwel tilqima 6-8 ġimgħat qabel it-tifriħ u tilqima oħra 3-4 ġimgħat aktar tard).
English: The risk using this inactivated vaccine can be classified as minimal.
Maltese: Ir-riskju li jintuża dan il-vaċċin inattivat jista' jiġi kklassifikat bħala minimu.
English: Results demonstrated that the vaccination of sows, gilts and boars according to the vaccination programme did not provoke unacceptable local or systemic reactions after vaccination and no significant differences in reproductive parameters between vaccinated and placebo-treated animals were recorded either.
Maltese: Ir-riżultati juru li tilqim tal-majjali nisa, tal-qżieqeż nisa u tal-majjali rġiel skont il-programm ta' tilqim ma ħolqux reazzjonijiet sistemiċi jew lokali inaċċettabbli wara t-tilqim u lanqas ma ġew irreġistrati differenzi fil-parametri riproduttivi bejn annimali mlaqqmin u annimali kkurati bi plaċebo.
English: What is the risk associated with RHINISENG?
Maltese: X'inhu r-riskju assoċjat ma' RHINISENG?
English: RHINISENG is used for the protection of piglets via the sow's colostrum (first milk) after injection of sows and gilts.
Maltese: RHINISENG jintuża għall-protezzjoni ta' qżieqeż permezz tal-kolostru (l-ewwel ħalib) tal-majjali nisa wara injezzjoni tal-majjali nisa u tal-qżieqeż nisa.
English: It may harm them, even if their signs of illness are the same as yours.
Maltese: Is-sinjali ta' tossiċita osservati fil-bhejjem (ġrieden u firien) kienu jinkludu tnaqqis fl-attivita , atassja, qtugħ ta' nifs u tregħid.
English: Clarithromycin 14-OH clarithromycin metabolite
Maltese: Metabolat 14-OH clarithromycin
English: Dose of NORVIR (mg)
Maltese: Doża ta' NORVIR (mg)
English: β2-agonist (long acting)
Maltese: β2-agonist (iħalli effett fit-tul)
English: Silica, colloidal anhydrous Polysorbate 80
Maltese: Silica, colloidal anyhdrous Polysorbate 80
English: Bupropion is primarily metabolised by CYP2B6.
Maltese: Bupropion huwa primarjament metabolizzat b' CYP2B6.
English: Stevens Johnson syndrome, toxic epidermal necrolysis (TEN)
Maltese: Sindromu Stevens Johnson, Nekroliżi tossika tal-epidermide (TEN)
English: Store below 30°C.
Maltese: Aħżen f'temperatura taħt 30ºC.
English: Alpha1-Adrenoreceptor Antagonist
Maltese: Antagonist Alpha1-Adrenoreceptor
English: • laboratory test results:
Maltese: • riżultati tat-testijiet tal-laboratorju:
English: Date of first authorisation: 26 August 1996 Date of latest renewal: 26 August 2006
Maltese: Data tal-aħħar tiġdid tal-awtorizzazzjoni: 26 ta' Awissu 2006
English: raltegravir, zidovudine);
Maltese: maraviroc, raltegravir, zidovudine);
English: Norbuprenorphine Glucuronide metabolites
Maltese: Buprenorphine Norbuprenorphine Metabolati Glucuronide
English: Phosphodiesterase (PDE5) inhibitors
Maltese: Impedituri Phosphodiesterase (PDE5)
English: Norvir 100 mg tablets
Maltese: Norvir 100 mg pillola
English: Rifabutin1 25-O-desacetyl rifabutin metabolite
Maltese: Rifabutin1 Metabolat 25-O-desacetyl rifabutin
English: Ergot Derivatives
Maltese: Derivattivi talErgotina
English: ↑ 152% ND
Maltese: Nelfinavir ↑ 152%
English: Amphetamine
Maltese: Amfetamina
English: Pethidine Norpethidine metabolite
Maltese: Metabolat Norpethidine
English: Polyethylene/aluminium/polyethylene terephthalate foil sachet.
Maltese: Qartas tal-fojl tal-polyethylene/aluminium/polyethylene terephthalate. 30 qratas f'kull kartuna.
English: ibrutinib, nilotinib, venetoclax, vincristine, vinblastine);
Maltese: Dasatinib, nilotinib, vincristine, vinblastine
English: Step 8.
Maltese: Stadju 8.
English: Norvir contains the active substance ritonavir.
Maltese: Norvir fih is-sustanza attiva ritonavir.
English: Astemizole, terfenadine Increased plasma concentrations of astemizole and terfenadine.
Maltese: Astemizole, terfenadine Żieda fil-konċentrazzjoni fil-plażma ta' astemizole u terfenadine.
English: − The tablet coating is composed of: hypromellose, titanium dioxide, macrogols, hydroxypropyl cellulose, talc, colloidal anhydrous silica, polysorbate 80.
Maltese: - Ir-rita ta' barra tal-pillola hija magħmula minn: hypromellose, titanium dioxide, macrogols, hydroxypropyl cellulose, colloidal anhydrous silica, polysorbate 80.
English: The AUC of the metabolite prednisolone increased by 37 and 28% after 4 and 14 days ritonavir, respectively.
Maltese: LAUC tal-metabolit prednisolone żdied b'37 u 28% wara 4 u 14 -il ġurnata b'ritonavir, rispettivament.
English: Reduction in the antiretroviral activity of ritonavir is primarily associated with the protease mutations V82A/F/T/S and I84V.
Maltese: Nuqqas fl-attivita antiretrovirali ta' ritonavir huwa primarjament assoċjat mal-mutazzjoni tal-protejaż V82A/F/T/S u I84V.
English: Clozapine, pimozide Increased plasma concentrations of clozapine and pimozide.
Maltese: Clozapine, pimozide Żieda fil-konċentrazzjoni fil-plażma ta' clozapine u pimozide.
English: For the full list of excipients, see section 6.1.
Maltese: Għal-lista kompleta ta'eċċipjenti, ara sezzjoni 6.1.
English: - Digoxin (heart medicine).
Maltese: - Digoxin (mediċina għall-qalb).
English: - Sildenafil or tadalafil for impotence (erectile dysfunction).
Maltese: - Sildenafil jew tadalafil għall-impotenza (disfunsjoni erettili).
English: Uncommon Acute renal failure
Maltese: Mhux komuni Indeboliment renali akut
English: Zolpidem200, 4 doses ↑ 28%
Maltese: Zolpidem200, 4 dożi
English: Musculosketal and connective tissue disorders
Maltese: Disturbi muskolu-skeltrali u talconnective tissue
English: The mean average change from baseline over 16 weeks for HIV RNA levels was -0.79 log10 (maximum mean decrease: 1.29 log10) in the ritonavir group versus -0.01 log10 in the control group.
Maltese: HIV RNA fuq perijodu ta'16 -il ġimgħa kien ta' 0.79 log10 (medja ta' tnaqqis massimu: 1.29 log10) fil-grupp ta' ritonavir kontra -0.01 log10 fil-grupp ta' kontroll.
English: Paediatric dosage guidelines for Norvir powder for oral suspension (prepared as 100 mg/10 ml)*†
Maltese: Linji gwida għal dożaġġ pedjatriku ta' trab għal suspensjoni orali ta' Norvir (ippreparat bħala 100 mg/10 ml) *†
English: Mix thoroughly (see Figure 5).
Maltese: Ħallat sewwa (ara Figura 5).
English: Step 11.
Maltese: Stadju 11.
English: How to take Norvir
Maltese: Tiħux Norvir
English: Food slightly decreases the bioavailability of the Norvir tablet.
Maltese: L-ikel inaqqas kemm mhux xejn il-biodisponibiltà tal-pillola Norvir.
English: - amphetamine or amphetamine derivatives; - antibiotics (e.g. erythromycin, clarithromycin); - anticancer treatments (e.g. abemaciclib, afatinib, apalutamide, ceritinib, encorafenib, dasatinib,
Maltese: - amfetamina jew derivattivi tal-amfetamina; - anti-bijotiċi (e.ż. erythromycin, clarithromycin); - trattamenti għal kontra l-kanċer (e.ż. abemaciclib, afatinib, apalutamide, ceritinib, encorafenib,
English: Amprenavir ↑ 2.4 fold ↑ 11 fold
Maltese: Amprenavir ↑ bi 2.4 drabi ↑ bi 11 -il darba
English: Accumulation of other mutations in the protease gene (including at positions 20, 33, 36, 46, 54, 71, and 90) can also contribute to ritonavir resistance.
Maltese: L-akkumulazzjoni ta' mutazzjonijiet oħra fil-ġene tal-protejaż (inkluż f'pożizzjonijiet 20, 33, 36, 46, 54, 71, u 90) tista' tikkontribwixxi ukoll għar-resistenza għal ritonavir.
English: − amphetamine or amphetamine derivatives;
Maltese: Derivattivi tal-Amfetamina
English: The apparent volume of distribution (VB/F) of ritonavir is approximately 20 - 40 l after a single 600 mg dose.
Maltese: Il-volum apparenti ta' distribuzzjoni (VB/F) ta' ritonavir hu bejn wieħed u ieħor 20 - 40 1 wara doża waħda ta' 600 mg.
English: - Symptoms of infection - inform your doctor immediately.
Maltese: - Sintomi ta' infezzjoni - informa lit-tabib tiegħek immedjatament.
English: AbbVie Deutschland GmbH & Co. KG, Knollstrasse, 67061 Ludwigshafen, Germany AbbVie Logistics B.V., Zuiderzeelaan 53, 8017 JV Zwolle, The Netherlands
Maltese: Trab għal suspensjoni orali biss AbbVie Logistics B.V., Zuiderzeelaan 53, 8017 JV Zwolle, The Netherlands
English: Step 10.
Maltese: Stadju 10.
English: Administration of a single 100 mg dose of Norvir tablet with a moderate fat meal (857 kcal, 31% calories from fat) or a high fat meal (907 kcal, 52% calories from fat) was associated with a mean decrease of 20-23% in ritonavir AUC and Cmax.
Maltese: It-teħid ta' doża waħda ta' 100 mg ta' pillola Norvir ma' ikla li fiha kontenut ta' xaħam moderat (857 kcal, 31% tal-kaloriji mixxaħam) jew ma' ikla li fiha kontenut għoli ta' xaħam (907 kcal, 52% tal-kaloriji mix-xaħam) ġie assoċjat ma' tnaqqis medju ta' bejn 20-23% fl-AUC u Cmax ta' ritonavir.
English: ibrutinib, nilotinib, venetoclax, vincristine, vinblastine); - anticoagulants (e.g. rivaroxaban, vorapaxar, warfarin) - antidepressants (e.g. amitriptyline, desipramine, fluoxetine, imipramine, nefazodone,
Maltese: dasatinib, ibrutinib, nilotinib, venetoclax, vincristine, vinblastine); - mediċini għal kontra l-koagulazzjoni tad-demm (e.ż. rivaroxaban, vorapaxar, warfarin); - anti-dipressanti (e.ż. amitriptyline, desipramine, fluoxetine, imipramine, nefazadone,
English: In a healthy volunteer drug interaction study of delamanid 100 mg twice daily and lopinavir/ritonavir 400/100 mg twice daily for 14 days, the exposure of the delamanid metabolite DM-6705 was 30% increased.
Maltese: Fi studju ta' interazzjoni tal-mediċina fuq voluntier b'saħħtu, b'100mg delamanid 100mg darbtejn kuljum u lopinavir/ritonavir 400/100 mg darbtejn kuljum għal 14 -il ġurnata, l-espożizzjoni tal-metabolit ta'delamanid DM-6705 kien 30% miżjud.
English: Common Hypercholesterolaemia, hypertriglyceridaemia, gout, oedema and peripheral oedema, dehydration (usually associated with gastrointestinal symptoms)
Maltese: Iperkolesterolemija, ipertrigliċeridemija, gotta, edima u edima periferali, deidrazzjoni (normalment assoċjata ma' sintomi gastrointestinali)
English: Step 12.
Maltese: Stadju 12.
English: The Marketing Authorisation Holder shall submit periodic safety update reports for this product in accordance with the requirements set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and published on the European medicines web-portal.
Maltese: Id-detentur tal-awtorizzazzjoni għat-tqegħid fis-suq għandu jippreżenta rapporti perjodiċi aġġornati dwar is-sigurtà għal dan il-prodott f'konformità mar-rekwiżiti mniżżla fil-lista tad-dati ta' referenza tal-Unjoni (lista EURD) prevista skont l-Artikolu 107c(7) tad-Direttiva 2001/83/KE u ppubblikati fuq il-portal elettroniku Ewropew tal-mediċini.
English: (µg•h/ml) t½ (h)
Maltese: (Jekk ikun meħtieġ)
English: HCV Direct Acting Antiviral
Maltese: Antiviral li jaġixxi direttament kontra l-HCV
English: Step 9.
Maltese: Stadju 9.
English: Step 2.
Maltese: Stadju 2.
English: Immediately wash the spoon and cup in warm water and dish soap (see Figure 7).
Maltese: Aħsel l-imgħarfa u t-tazza fl-ilma sħun u fis-sapun tal-platti (ara Figura 7).
English: Ελλάδα AbbVie ΦΑΡΜΑΚΕΥΤΙΚΗ Α.Ε.
Maltese: Sewqan u tħaddim ta' magni
English: • Close the lid and shake hard for at least 90 seconds until all the lumps have dissolved.
Maltese: • Agħlaq l-għatu u ħawwad b'mod qawwi għal mill-inqas 90 sekonda sakemm ċ-ċapep ikunu maħlula.
English: Concomitant use of Norvir with lomitapide is contraindicated (see prescribing information for lomitapide) (see section 4.3).
Maltese: L-użu konkomitanti ta' Norvir ma' lomitapide huwa kontraindikat (ara l-informazzjoni dwar kif jiġi preskritt lomitapide) (ara sezzjoni 4.3).
English: Very common Pruritus, rash (including erythematous and maculopapular)
Maltese: Komuni ħafna Prurite, raxx (li jinkludi dawk tat-tip erythematous u maculopapular)
English: 200 q12h/1h before 200 q12h/ coadministered 200 q12h/6h after Serum concentrations may be increased due to Breast Cancer Resistance Protein (BCRP) and acute P-gp inhibition by ritonavir.
Maltese: 200 q12h/1h qabel 200 q12h/ coamministrat 200 q12h/6h wara Konċentrazzjonijiet tas-serum jistgħu jiżdiedu minħabba l-inibizzjoni talProteina Reżistenti għall-Kanċer tas-Sider (BCRP) u l-inibizzjoni akuta tal-P gp minn ritonavir.
English: Increased plasma concentrations of avanafil (see section 4.4. and 4.5).
Maltese: Żieda fil-konċentrazzjoni fil-plażma ta' avanafil (ara sezzjoni 4.4 u 4.5).
English: Step 1.
Maltese: Stadju 1.
English: Common Increased urination, renal impairment (e.g. oliguria, elevated creatinine)
Maltese: Żieda fl-awrina, indeboliment renali (e.ż. oligurja, żieda fil-kreatinina)
English: България АбВи ЕООД
Maltese: Suomi/Finland AbbVie Oy
English: ↑ 86% ND
Maltese: Atazanavir ↑ 86%
English: AbbVie Deutschland GmbH & Co. KG, Knollstrasse, 67061 Ludwigshafen, Germany
Maltese: KG, Knollstrasse, 67061 Ludwigshafen, il-Ġermanja
English: (For caution on parenterally administered midazolam, see section 4.5).
Maltese: (Sabiex tiġi eżerċitata kawtela meta midazolam jiġi mgħoti parenteralment, ara sezzjoni 4.5).
English: − The other tablet ingredients are: copovidone, sorbitan laurate, anhydrous calcium hydrogen phosphate, colloidal anhydrous silica, sodium stearyl fumarate.
Maltese: - Is-sustanzi l-oħra tal-pillola huma: copovidone, sorbitan laurate, anhydrous calcium hydrogen phosphate, colloidal anhydrous silica, sodium stearyl fumarate.
English: In intent to treat analyses, 72% and 36% of patients achieved reduction in plasma HIV-1 RNA of ≤ 400 copies/ml at Week 16 and 104, respectively.
Maltese: F'analażi tal-intenzjoni biex tfejjaq,72% u 36% talpazjenti laħqu tnaqqis tal-HIV-1 RNA fil-plażma ta'  400 kopja/ml f'Ġimgħa numru 16 u 104, rispettivament.
English: 10, single dose 600 q12h ↑ 153% ↑ 55% Inhibition of CYP3A and P-gp lead to increased plasma levels and pharmacodynamic effects of rivaroxaban which may lead to an increased bleeding risk.
Maltese: 10, doża waħda 600 q12h ↑ 153% ↑ 55% Inibizzjoni ta' CYP3A u P-gp jwassal għal żieda fil-livelli tal-plasma u leffetti farmakodinamiċi ta' rivaroxaban li jista' jwassal għal żieda firriskju ta' fsada.
English: Uncommon Myocardial infarction
Maltese: Mhux komuni Infart mijokardijaku
English: Common Increased amylase, decreased free and total thyroxin
Maltese: Żieda fl-amylase, tnaqqis fit-thyroxin ħieles u totali
English: ↑ 72% ND
Maltese: Ritonavir ↑ 72%
English: Increased plasma concentrations of vardenafil (see section 4.4. and 4.5).
Maltese: Żieda fil-konċentrazzjoni fil-plażma ta' vardenafil (ara sezzjoni 4.4 u 4.5).
English: Systemic corticosteroid effects including Cushing's syndrome and adrenal suppression (plasma cortisol levels were noted to be decreased 86% in the above study) have been reported in patients receiving ritonavir and inhaled or intranasal fluticasone propionate; similar effects could also occur with other corticosteroids metabolised by CYP3A e.g., budesonide and triamcinolone.
Maltese: Effetti tal-corticosteroids sistematiċi inkluż is-sindromu Cushing u soppressjoni adrenali (fl-istudju t'hawn fuq ġie nnotat li l-livelli talcortisol fil-plażma naqsu 86%) ġew rapportati f'pazjenti li jieħdu ritonavir u li jiġbdu f'imnifsejhom jew idaħħlu fl-imnieħer fluticasone propionate; jistgħu jirriżultaw effetti simili b'corticosteroids oħra metabolizzati b' CYP3A e.ż.,budesonide u triamcinolone.
English: fosamprenavir, indinavir, nelfinavir, saquinavir, tipranavir), non-nucleoside reverse transcriptase inhibitors (NNRTI) (delavirdine, efavirenz, nevirapine), and others (didanosine, maraviroc,
Maltese: fosamprenavir, indinavir, nelfinavir, saquinavir, tipranavir), impedituri reverse transcriptase li m'humiex nucleoside (NNRTI) (delavirdine, efavirenz, nevirapine), u oħrajn (didanosine,
English: Powder for oral suspension.
Maltese: Trab għal suspensjoni orali
English: nortriptyline, paroxetine, sertraline, trazodone); - antifungals (e.g. ketoconazole, itraconazole); - antihistamines (e.g. loratadine, fexofenadine); - antiretroviral medicines, including HIV-protease inhibitors (amprenavir, atazanavir, darunavir,
Maltese: sertraline, trazodone); - mediċini għal kontra l-fungu (e.ż. ketoconazole, itraconazole); - mediċini għal kontra l-istamina (e.ż. loratidine, fexofenadine); - mediċini antiretrovirali, inklużi mpedituri protejaż HIV (amprenavir, atazanavir, darunavir,
English: Norvir film-coated tablets are white debossed with [Abbott logo] and the code “NK”.
Maltese: Il-pilloli miksija b'rita Norvir huma bojod bil-[lowgo ta' Abbott] u l-kodiċi “NK” imnaqqxa fihom.
English: Amprenavir2 ↑ 64% ↑ 5 fold
Maltese: ↑ 64% ↑ b'5 darbiet
English: ↔ ↑ 4 fold
Maltese: ↔ ↑ b'4 darbiet
English: The safety profile of Norvir in children 2 years of age and older is similar to that seen in adults.
Maltese: L-profil tas-sigurtà ta' Norvir fit-tfal ta' sentejn u anzjani huwa simili għal dak li deher fl-adulti.
English: - buprenorphine, a medicine used for the treatment of chronic pain; - bupropion, a medicine used to help you stop smoking; - epilepsy medicines (e.g. carbamazepine, divalproex, lamotrigine, phenytoin); - heart medicines (e.g. disopyramide, mexiletine and calcium channel antagonists such as amlodipine, diltiazem and nifedipine); - immune system medicines (e.g. cyclosporine, tacrolimus, everolimus); - levothyroxine (used to treat thyroid problems); - morphine and morphine-like medicines used to treat severe pain (e.g. methadone, fentanyl); - sleeping pills (e.g. alprazolam, zolpidem) and also midazolam administered by injection; - tranquillisers (e.g. haloperidol, risperidone, thioridazine); - colchicine, a treatment for gout.
Maltese: (e.ż. glecaprevir/pibrentasvir u simeprevir); - mediċina għal kontra l-ansjetà, buspirone; - mediċina għal kontra l-ażżma, theophylline, salmeterol; - atovaquone, mediċina użata għat-trattament ta' ċertu tip ta' pnewmonja u malarja; - buprenorphine, mediċina użata għat-trattament ta' uġigħ kroniku; - bupropion, mediċina użata biex tgħinek tieqaf tpejjep; - mediċini għall-epilessija (e.ż. carbamazepine, divalproex, lamotrigine, phenytoin); - mediċini għall-qalb (e.ż. disopyramide, mexiletine u mediċini li jaħdmu kontra l-kanali tal kalċju bħal amlodipine, diltiazem u nifedipine); - is-sistema immunitarja (e.ż. cyclosporine, tacrolimus, everolimus); - levothyroxine (jintuża biex jittratta problemi tat-tirojde); - morfina u mediċini simili għall-morfina użati għat-trattament ta' uġigħ kbir ħafna (e.ż.
English: Other medicines and Norvir
Maltese: Mediċini oħra u Norvir
English: raltegravir, zidovudine); - anti-tuberculosis medicine (bedaquiline and delamanid); - antiviral medicine used to treat chronic hepatitis C virus (HCV) infection in adults (e.g.
Maltese: maraviroc, raltegravir, zidovudine); - mediċina ta' kontra t-tuberkolosi (bedaquiline u delamanid); - mediċina antivirali użata biex tittratta infezzjoni kronika mill-virus tal-epatite Ċ (HCV) f'adulti
English: - The other ingredients are copovidone; sorbitan laurate; silica, colloidal anhydrous.
Maltese: Is-sustanzi l-oħra huma copovidone; sorbitone laurate; silica, colloidal anhydrous.
English: The recommended dose of Norvir film-coated tablets is 600 mg (6 tablets) twice daily (total of 1200 mg per day) by mouth.
Maltese: Id-doża rrakkomandata tal-pilloli miksija b'rita Norvir hija ta' 600 mg (6 pilloli) darbtejn kuljum (total ta' 1200 mg kuljum) mill-ħalq.
English: Step 6.
Maltese: Stadju 6.
English: Step 7.
Maltese: Stadju 7.
English: Administration of a single 100 mg dose of ritonavir powder for oral suspension with a moderate fat meal (617 kcal, 29% calories from fat) was associated with a mean decrease of 23 and 39% in ritonavir AUCinf and Cmax respectively, relative to fasting conditions.
Maltese: Għoti ta' doża waħda ta' 100 mg tat-trab għal-suspensjoni orali ta' ritonavir ma' ikla b'ammont moderat ta' xaħam (617 kcal, 29% kaloriji mix-xaħam) kien assoċjat ma' tnaqqis medju ta' 23 u 39% fl-AUCinf u Cmax rispettivament, relattiv għall-kundizzjonijiet ta' sawm.
English: Common Hepatitis (including increased AST, ALT, GGT), blood bilirubin increased (including jaundice)
Maltese: Epatite (li tinkludi żieda fl-AST, ALT, GGT), żieda fil-bilirubin fid-demm (li tinkludi suffejra)
English: Norvir can cause dizziness.
Maltese: Norvir jista' jikkawża sturdament.
English: A controlled study completed in 1996 with ritonavir as add-on therapy in HIV-1 infected patients extensively pre-treated with nucleoside analogues and baseline CD4 cell counts ≤ 100 cells/µl showed a reduction in mortality and AIDS defining events.
Maltese: Studju kkontrollat komplet fl-1996 li sar b'ritonavir bħala terapija addizzjonali fuq pazjenti infettati bl-HIV-1 u li kienu preċedentement ittrattati estensivament b'analogi ta' nukleòside u b'għadd ta' ċellulli tal-linja bażi CD4  100 ċelluli /l, urew tnaqqis fil-mortalità u fl-avvenimenti li jiddefinixxu l-AIDS.
English: Atazanavir ↑ 86% ↑ 11 fold Atazanavir1 ↑ 2 fold ↑ 3-7 fold
Maltese: Atazanavir ↑ 86% ↑ bi 11 -il darba
English: • severe or life threatening skin reaction including blisters (Stevens Johnson syndrome, toxic epidermal necrolysis)
Maltese: • reazzjonijiet fil-ġilda severi jew li jpoġġu lħajja fil-periklu, inklużi bżieżaq (issindromu Stevens Johnson, nekroliżi tossika tal-epidermide)
English: The protein binding of ritonavir in human plasma is approximately 98 - 99% and is constant over the concentration range of 1.0 - 100 µg/ml.
Maltese: It-tweħħil ta' ritonavir mal-proteini tad-demm fil-plażma tal-bniedem huwa ta' bejn wieħed u ieħor 98 99% u huwa kostanti tul il-medda ta' konċentrazzjoni ta' bejn 1.0 - 100 g/ml.